美国 · 经济杂志 · Inc.

This Breakthrough Cancer Treatment Can Cut Risk by 42 Percent

来源：Inc. · 美国 2 小时前

A groundbreaking phase 3 clinical trial reveals that a personalized mRNA vaccine from Merck and Moderna significantly cuts the risk of melanoma returning.

在 Inc. 阅读全文登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.inc.com)

This Breakthrough Cancer Treatment Can Cut Risk by 42 Percent

推荐阅读

12 things to do in Istanbul, from Hagia Sophia to a Bosphorus ferry

A $44 million superhero horror film won the box office this weekend. A $7 million documentary came within $5 million of beating it

Stocks Start a Big Week With Solid Gains: Stock Market Today

Microsoft offers voluntary buyouts to 60,000 employees as tech giant reshapes its workforce

Entrepreneurship might be the key to a longer life

Megan Thee Stallion Says This Is the ‘Biggest Mistake’ She Made Early in Her Career — And How She Fixed It

This Breakthrough Cancer Treatment Can Cut Risk by 42 Percent

分享

推荐阅读

12 things to do in Istanbul, from Hagia Sophia to a Bosphorus ferry

A $44 million superhero horror film won the box office this weekend. A $7 million documentary came within $5 million of beating it

Stocks Start a Big Week With Solid Gains: Stock Market Today

Microsoft offers voluntary buyouts to 60,000 employees as tech giant reshapes its workforce

Entrepreneurship might be the key to a longer life

Megan Thee Stallion Says This Is the ‘Biggest Mistake’ She Made Early in Her Career — And How She Fixed It